Document is current
Any future updates will be listed below
-
Authors
Masuda, Takashi
Funakoshi, Taro
Horimatsu, Takahiro
Masui, Sho
Hira, Daiki
Inoue, Marin
Yajima, Kodai
Nakagawa, Shunsaku
Ikemi, Yasuaki
Hamanishi, Junzo
Takai, Atsushi
Yamamoto, Shinya
Matsubara, Takeshi
Mandai, Masaki
Seno, Hiroshi
Yanagita, Motoko
Muto, Manabu
Terada, Tomohiro
Yonezawa, Atsushi
-
Funding
Funding for this research was provided by:
JST SPRING (JPMJSP2110)
Grant-in-Aid for Scientific Research (B) (19H03389, 23H02649)
Mochida Memorial Foundation for Medical and Pharmaceutical Research
- License Information
-
More Information
Article History
Received: 18 October 2024
Accepted: 6 March 2025
First Online: 21 March 2025
Declarations
:
: J.H. has received a research grant from Chugai Pharmaceutical Co., Ltd. M.Y. has received research grants and/or speaking fee from Mitsubishi Tanabe Pharma Corporation, Chugai Pharmaceutical CO., LTD., Astellas Pharma Inc., AstraZeneca K.K., Kyowa Kirin Co., Ltd., Bayer Yakuhin, Ltd., and Boehringer Ingelheim GmbH. M.Muto. has received a research grant and speaking fee from Chugai Pharmaceutical Co., Ltd. A.Y. has received a research grant from Shimadzu Corporation.
: The current study adhered to the principles of the Declaration of Helsinki and was approved by the Medical Ethics Committee of the Kyoto University Graduate School and Faculty of Medicine (Approval No. R2643).
: Written informed consent for participation in this study was obtained from all patients.
: Patients signed informed consent regarding publishing their data.
